Outlook Therapeutics, Inc. (OTLK) › Weighted Average Diluted SharesOutlook Therapeutics, Inc. (OTLK) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2016-09-30: 17.21M2017-09-30: 24.04M2018-09-30: 39.46M2020-09-30: 72.56M2021-09-30: 152.68M2022-09-30: 212.08M2023-09-30: 12.51M2024-09-30: 18.55M2025-09-30: 34.80M34.80M2016-09-30Weighted Average Diluted Shares (shares)2025-09-30Period endedWeighted Average Diluted SharesChange YoYSource filing2025-09-3034.80M+87.6%2025-12-19From 2024-10-012024-09-3018.55M+48.3%2025-12-19From 2023-10-012023-09-3012.51M-94.1%2024-12-27From 2022-10-012022-09-30212.08M+38.9%2023-12-22From 2021-10-012021-09-30152.68M+110.4%2022-12-29From 2020-10-012020-09-3072.56M—2021-12-23From 2019-10-012018-09-3039.46M+64.1%2018-12-18From 2017-10-012017-09-3024.04M+39.7%2018-12-18From 2016-10-012016-09-3017.21M—2017-12-29From 2015-10-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)